Literature DB >> 16139999

Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?

J Brinckmann1, S Kim, J Wu, D P Reinhardt, C Batmunkh, E Metzen, H Notbohm, R A Bank, T Krieg, N Hunzelmann.   

Abstract

The major pathological processes of systemic scleroderma (SSc) comprise inflammation and microvascular damage in the early or acute progressive stage as well as tissue fibrosis and hypoxia in the chronic end stage. Fibrosis seems to be a general phenomenon characterized by an increase of hydroxylysine aldehyde derived collagen cross-links which has been shown in vitro for systemic scleroderma fibroblasts. In the present study, we analyzed the cross-link pattern and the gene expression of lysyl hydroxylase 2 (LH2) in the skin of SSc. Furthermore, we determined the modulatory impact of inflammatory cytokines (interleukin 4, TNF- alphaand interleukin 1alpha/beta) and prolonged hypoxia on the cross-link profile and the gene expression of LH2, respectively. The concentration of hydroxylysine aldehyde derived cross-links was significantly increased in SSc, while the level of lysine aldehyde derived cross-links was not changed. Accordingly, a marked increase of the transcriptional level of LH2 was found. In long term dermal fibroblast cultures, only interleukin 4 induced an increase of hydroxylysine aldehyde derived cross-links accompanied by a higher gene expression of LH2. Furthermore, prolonged hypoxia induced a marked increase of the mRNA level of LH2 in relation to collagen I. The skin of SSc is characterized by an increase of the transcriptional activity of LH2 leading to an altered cross-link pattern. The changes in the quality of the collagenous matrix can also be obtained in cell culture by the exposure of fibroblasts to interleukin 4 or prolonged hypoxia emphasizing the role of this mediator in the acute and the low oxygen tension in the chronic phase of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139999     DOI: 10.1016/j.matbio.2005.07.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  26 in total

Review 1.  T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.

Authors:  Francesco Del Galdo; Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

Authors:  Sebastian Willenborg; Beate Eckes; Jürgen Brinckmann; Thomas Krieg; Ari Waisman; Karin Hartmann; Axel Roers; Sabine A Eming
Journal:  J Invest Dermatol       Date:  2014-01-09       Impact factor: 8.551

Review 3.  [Current pathophysiological aspects of systemic sclerosis].

Authors:  T Krieg; N Hunzelmann
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

4.  Interleukin-4 Receptor α Signaling in Myeloid Cells Controls Collagen Fibril Assembly in Skin Repair.

Authors:  Johanna A Knipper; Sebastian Willenborg; Jürgen Brinckmann; Wilhelm Bloch; Tobias Maaß; Raimund Wagener; Thomas Krieg; Tara Sutherland; Ariel Munitz; Marc E Rothenberg; Anja Niehoff; Rebecca Richardson; Matthias Hammerschmidt; Judith E Allen; Sabine A Eming
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

Review 5.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

6.  Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation.

Authors:  Yan Huang; Xu Yan; Mei J Zhu; Richard J McCormick; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-06       Impact factor: 4.310

7.  Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.

Authors:  Ping Chen; Andreas Dendorfer; Rocio K Finol-Urdaneta; Heinrich Terlau; Baldomero M Olivera
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

8.  Missense mutations that cause Bruck syndrome affect enzymatic activity, folding, and oligomerization of lysyl hydroxylase 2.

Authors:  Marjo Hyry; Juha Lantto; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

9.  Hypoxia-induced collagen crosslinking as a mechanism for enhancing mechanical properties of engineered articular cartilage.

Authors:  E A Makris; J C Hu; K A Athanasiou
Journal:  Osteoarthritis Cartilage       Date:  2013-01-23       Impact factor: 6.576

Review 10.  Molecular and cellular basis of scleroderma.

Authors:  Beate Eckes; Pia Moinzadeh; Gerhard Sengle; Nico Hunzelmann; Thomas Krieg
Journal:  J Mol Med (Berl)       Date:  2014-07-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.